Molecular Design Platform Accelerating Research For Huntington’s Disease
OpenEye Scientific and CHDI Foundation Announce Collaboration on Small-Molecule Computational Research for Huntington’s Disease
SANTA FE, N.M., & NEW YORK, N.Y. – July 28, 2020 – OpenEye Scientific (OpenEye) and CHDI Foundation (CHDI) today announced a research collaboration to identify novel small-molecule therapeutics for Huntington’s disease (HD) utilizing Orion, OpenEye’s cloud-native molecular design platform. Read more…